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WITHIN THE INTERSTITIAL MACROMOLECULAR SCAFFOLD, tissue fluid is partially bound to the polyanionic macromolecules like hyaluronan (HA) and proteoglycans (PG) and partially freely moving within the surrounding porous mesh. While the two fluid components are in equilibrium with each other, the maintenance of the steady-state interstitial fluid turnover is provided by the reciprocal control between at least three distinct phenomena: 1) fluid entrance in the tissue through the microvascular wall down transendothelial hydraulic and colloidosmotic pressure gradients, 2) convective outflows of fluid and solutes into the initial lymphatic system, and 3) the mechanical properties of the solid elements of the interstitial matrix. Either a qualitative and/or a quantitative change of each of these three components modifies the balance shifting to a new steady-state condition that may not be compatible with adequate tissue function. Although tissues may be subject to a certain degree of dehydration, the most likely cause of interstitial fluid unbalance is increased tissue hydration. In the lung parenchyma edema is associated with several types of pathologies and consists of a diffuse accumulation of fluid in the extravascular interstitial tissue and, in case of severe edema, also in the alveolar air space.
The early development of interstitial pulmonary edema has been shown to be associated to a degradation of the PG molecular family and a weakening of the intermolecular bonds between fibers resulting in a disorganization of the threedimensional matrix fiber mesh. The loss of intermolecular constraints makes the pulmonary interstitial space mechanically more compliant (6, 12) , increasing the amount of water that can be accommodated in the tissue and progressively leading to interstitial and, eventually, alveolar lung edema. This behavior has been demonstrated to come into play in the development of hydraulic edema caused by slow infusion of saline solution (6) as well as in lesional edema induced by increasing the plasma concentration of the proteolytic enzyme pancreatic elastase (11) . Notwithstanding the completely different etiology of lung edema in those studies, the mechanical response of the solid interstitial matrix was similar in the two types of edema and consisted on one hand in counteracting the initial onset of edema formation and on the other in allowing fluid accumulation once the matrix integrity was disrupted.
Although these sets of experiments revealed the important role of the solid matrix in controlling lung tissue hydration, saline as well as elastase infusion resulted in a nonspecific cleavage of several PG families, failing to attribute a specific role to any of the matrix macromolecules. Hence, in the present study we aimed at describing the mechanical properties and the biochemical structural modification of the pulmonary parenchyma after challenging the lung tissue with more specific lesional agents, i.e., collagenase or heparanase. The two enzymes display different properties; in fact, collagenase is a wide-spectrum proteolytic enzyme acting mainly on collagen type I fibers that build the three-dimensional environment of the interstitial space, whereas heparanase has a more specific activity, cleaving the heparan sulfate chains belonging to the PG molecules (15) . On considering that the heparan sulfate proteoglycans (HS-PG) primarily lay in the basement membrane of the endothelial and alveolar epithelial monolayer, the present data will be discussed in light of the contribution of the matrix macromolecules to the mechanical strength of the tissue but also of the role played by the endothelial barrier in edema onset.
MATERIALS AND METHODS
General preparation. Experiments were done in adult New Zealand rabbits (n ϭ 25), anesthetized with 2.5 ml/kg of a mixture of urethane at 25% in saline solution and 1.5 ml of pentobarbital sodium (60 mg/ml). Subsequent doses of anesthetic were given throughout the experiment judging from the arousal of ocular reflexes. The experimental protocol was performed in accordance with the national ethics committee guidelines and was approved by the Institutional Animal Care and Use Committee of the Italian Ministry of University and Research (MIUR).
The trachea was cannulated with a T-tracheal tube that was connected to a heated pneumotacograph (Hans Rudolph, model 8420) equipped with a dedicated pneumotach amplifier (Hans Rudolph, model 1110A). Saline-filled catheters were inserted in the carotid artery and into a jugular vein and were connected via three-way stopcocks to physiological pressure transducers (model P23XL, Gould Electronics) conveying the pressure signals to the corresponding amplifiers and to a signal conditioner (model 6600, Gould Electronics). The pressures and the flow signals were then digitized with an analog-to-digital board and displayed on the monitor screen using a dedicated LabView software (National Instruments). In addition, the flow signal was electronically integrated using with the same LabView software, and the respiratory tidal volume was also displayed on the monitor screen.
Measurement of pulmonary interstitial pressure in control situation and after lesional edema. A first group of animals [n ϭ 10, body wt ϭ 2.3 Ϯ 0.3 (SD) kg] was used to measure pulmonary interstitial fluid pressure (Pip) by micropuncture in control situations and after induction of lesional edema. With the spontaneously breathing animal lying supine, a "pleural window" was prepared on the right side of the chest at the level of the 6th or 7th intercostal space by resecting the external and internal intercostal muscles down to the endothoracic fascia. Under stereomicroscopic view, the endothoracic fascia was then carefully stripped over a surface area of ϳ0.2 cm 2 leaving intact the underlying parietal pleura, whose thickness (ϳ30 m) and transparency allowed observation of the intact lung surface. The prepared area was wet with saline solution and kept covered with Parafilm to avoid tissue dehydration before proceeding to micropuncture.
Glass micropipettes with tips beveled to 2-3 m and a taper of ϳ200 m were used. The micropipettes were filled with 1 M NaCl solution previously filtered (0.1-m Millipore filter). Each pipette was calibrated (pressure range Ϯ 30 cmH2O) after being seated in a holder and connected to a pressure transducer (Gould P23XL) motor driven by a servo-null system (model 5; Vista Electronics, Ramona, CA). The pressure signal was amplified, digitized, and analyzed as described for the arterial and venous pressure signals.
Before each measurement the electrical zero was obtained by insertion of the pipette in a saline pool placed at the height of the pleural window and grounded to the animal. Before micropuncture the animals were paralyzed with pancuronium bromide (2 mg/kg body wt) and mechanically ventilated through a ventilator delivering room air at the same tidal volume and frequency spontaneously chosen by the animal during the basal phase of spontaneous breathing.
The lung surface was observed though a stereomicroscope (magnification ϫ60 -100, Zeiss SV 11) whose image was captured by a digital video camera (Axiocam, Zeiss), processed by a dedicated board, and displayed on a color monitor with a maximal magnification on the video screen of ϫ200. Final magnification on the video screen was twofold higher. Digital images on the screen were stored through image analysis software (KS300, Zeiss).
At the time of micropuncture, the animal was placed in lateral decubitus, and the ventilator was disconnected for a period of ϳ5-10 min; in the apneic phase the animal was oxygenated by a constant flow of 50% O2 in nitrogen delivered through a thin intratracheal tubing with an outlet pressure of Ϸ1 cmH 2O. Under stereomicroscopic observation and with the aid of a three-dimensional hydraulic micromanipulators (Joystick Micromanipulator MO-188 or MO-109; Narishighe, Tokyo, Japan) equipped with a fourth micromanipulator movement, the pipette was advanced through the pleural surfaces and the pleural space until its tip was positioned into the perivascular interstitial space surrounding a pulmonary vessel (diameter from ϳ20 to 200 m) running over the lung surface. To minimize indentation of the tissues during insertion (7) the pipette was inclined at an angle of ϳ45°relative to the lung surface. Height of measurement was Ϸ60% of lung height relative to the lowest point of the chest in the lateral decubitus. Between successive micropunctures the animal was connected to the ventilator and passively ventilated with room air until the next measurement. The criteria for accepting micropipette recordings were: 1) an unchanged electrical zero on withdrawal of the pipette, 2) a stable recording for at least 1 min, and 3) similar values (within Ϯ2 cmH 2O) obtained from the same site on successive recordings. The latter criterion was met on a regular basis by repeating the pressure registration at the same site within a period of 3-5 min.
To favor the development of lesional pulmonary edema, a subgroup (group A, n ϭ 5) of rabbits received an intravenous bolus of 10,000 collagen digestion units of collagenase (type VII; Sigma, St. Louis, MO), whereas a different subgroup (group B, n ϭ 5) received 2 IU of heparanase (type III, Sigma). Measurements of all parameters, including P ip, were performed during the initial baseline control phase, before the enzymes injection and every 10 -20 min after collagenase or heparanase injection up to 180 min.
Blood samples (0.2 ml) were taken every 30 min throughout the experiment via heparanized tubing and syringes (heparin solution: 0.1 mg/ml). The blood was stored in presence of 1 mg/ml EDTA and subsequently partly used to determine hematocrit through a microcentrifuge; the remaining blood was centrifuged, and plasma protein concentration was directly measured through refractometry.
After ϳ3 h from collagenase or heparanase intravenous injection, the animals were killed with an anesthesia overdose. The chest was widely opened, and four samples of lung tissues were taken from each lung. The wet weight-to-dry weight (W/D) ratio of tissue samples from the lung was determined by weighing the samples fresh and after drying in an oven at 70°C for 24 h. To take into account the variability of the local W/D ratio within the same lung tissue due to the patchy nature of edema development, the W/D ratio was calculated on multiple samples of lung tissue excised from the ventral and dorsal areas.
Biochemical analysis of matrix macromolecules in lesional edema. A separate group of animals (n ϭ 15, body wt ϭ 2.6 Ϯ 0.2 kg) was used to assess the effect of collagenase and heparanase on the pulmonary interstitial PG structure and content. The animals were first anesthetized as described for the micropuncture experiments. After tracheotomy and cannulation of a jugular vein, they received an intravenous injection of either collagenase (n ϭ 6) or heparanase (n ϭ 6) and were then left to breathe spontaneously while supine. In each group, three rabbits were killed at 60 min and three at 180 min. A third group (n ϭ 3) was used as control and received a single lethal dose of anesthesia.
Immediately after death the chest was opened, and the lung was excised and frozen in liquid nitrogen to proceed with the biochemical analysis of the pulmonary tissue matrix.
Total PG content of lung tissue samples was evaluated by hexuronate assay, after papain digestion of the tissue (11, 12) . After centrifugation of the digested material (15,000 g for 1 h at 4°C), glycosaminoglycans (the polysaccharide component of PGs plus HA) were precipitated with 4 volumes of cold ethanol at Ϫ20°C and assayed for hexuronate content.
PGs were extracted from small tissue slices using the chaotropic agent guanidinium chloride (GuHCl, 4 M) in 50 mM sodium acetate buffer, pH 6.0 containing protease inhibitors (11, 12) at 4°C under mild stirring for 24 h. The extract was dialyzed against 8 M urea in 50 mM sodium acetate buffer, pH 5.8, 0.5% (vol/vol) Triton X-100, protease inhibitors (buffer A) containing 0.15 M NaCl, and PGs were then purified on DEAE Sephacel column (1.6 ϫ 50 cm, flow 12 ml/h) and washed with buffer A containing 0.15 M and 0.3 M NaCl. PGs were eluted with buffer A containing 1.2 M NaCl, and PGs containing peaks were concentrated using a concentrator equipped with a PM 10 membrane. Concentrated samples were precipitated with 9 volumes of ethanol at 4°C overnight and analyzed for uronate content, as previously described (12) . Aliquots (50 m as protein) of purified PGs were radiolabeled using 125 I as described elsewhere (11) and were analyzed by gel filtration chromatography using a Sepharose CL-4B column (1 ϫ 50 cm, flow 6 ml/h) eluted with 4 M GuHCl in 50 mM sodium acetate buffer, pH 6.0, containing protease inhibitors (11, 12) . The elution profiles were obtained measuring radioactive PGs in the fractions by gamma counter (11) .
Data analysis. Data are reported as means Ϯ SD. Absolute values were compared by one-way ANOVA. Differences between mean values were considered significant at P Ͻ 0.05. Whenever one-way ANOVA detected a significant difference between mean values, all pairwise multiple-comparison procedures were performed (Bonferroni t-test) through a standard statistical program (Sigmastat).
RESULTS
Under baseline conditions, the spontaneous breathing frequency and tidal volume were 18 Ϯ 1.5 cycles/min and 20.5 Ϯ 1.4 ml (n ϭ 10), respectively. Arterial and venous pressure averaged 97 Ϯ 2.3 mmHg and 2.6 Ϯ 1.9 cmH 2 O, respectively, in the baseline control phase and remained essentially steady after intravenous injection of either collagenase or heparanase and throughout the whole micropuncture phase. Protein concentration and hematocrit were 5.3 Ϯ 0.8 g/dl and 40.5 Ϯ 0.4% under baseline conditions, 4.7 Ϯ 0.4 g/dl and 42.8 Ϯ 1.4% after 180 min of collagenase, and 5.1 Ϯ 0.6 g/dl and 44.1 Ϯ 1.5% after 180 min of heparanase, respectively. P ip was recorded at heart level from the perivascular interstitial space surrounding arterioles on the costal surface of the lungs physiologically expanded at zero alveolar pressure, while the animals were lying supine. In control condition [time (t) ϭ 0], the average P ip value amounted to Ϫ9.3 Ϯ 1.5 cmH 2 O (n ϭ 5) and was significantly different from zero (P Ͻ 0.001). Subsequent recordings attained every 10 -20 min after intrajugular addition of collagenase (Fig. 1A) showed that in all individual experiments (n ϭ 5) P ip rose from the subatmospheric control value toward a positive peak to return thereafter toward zero or slightly negative values. Although the time course of individual P ip values differed slightly, the general P ip behavior was similar among individuals: hence, data presented in Fig. 1A were normalized by horizontally translating the P ip time course so as to consider the time at the attainment of the peak value as the zero reference time (Fig. 1B) . After this alignment and as described by the bold solid line in Fig. 1B , an average peak P ip of 4.5 Ϯ 0.3 cmH 2 O (n ϭ 5) was attained at 45 Ϯ 24 min from the addition of collagenase; subsequently P ip dropped to zero in ϳ120 min. The average peak P ip was significantly different from both the initial control value (P Ͻ 0.001) and from zero (P Ͻ 0.001).
At variance with what observed with collagenase, intravenous injection of heparanase (Fig. 2) caused P ip to increase from the significantly negative control value (P ip ϭ Ϫ9.7 Ϯ 2.1 cmH 2 O, n ϭ 5), toward zero or slightly negative values without ever attaining a positive P ip peak. On the average this process was completed in about 60 min and was quite reproducible between the animals (n ϭ 5) treated with heparanase.
The average time course of P ip obtained after collagenase and heparanase is presented in Fig. 3 and compared with the P ip behavior observed during development of interstitial pulmonary edema induced through slow intravenous saline infusion or elastase intravenous addition. After a similar initial increase in the first minute after enzyme addition, the P ip response to collagenase and heparanase dissociated, attaining a significant difference (t ϭ 3.16, P ϭ 0.036) between points a (heparanase treatment) and aЈ (collagenase treatment) at ϳ30 min from beginning of the enzymatic treatment. The difference between treatments became more evident (t ϭ 8.53, P Ͻ 0.001) with the attainment of a positive P ip peak (points bЈ) after collagenase but not heparanase (point b) treatment. Thereafter, the P ip time courses became more similar, although P ip remained somehow always slightly lower in heparanase compared with collagenase-treated lungs.
From the comparison of the curves presented in Fig. 3 , it is clear that the lack of a positive peak P ip was distinctive of the heparanase treatment: in fact, although with different P ip time courses, all other treatments resulted in a transient attainment of positive P ip values.
At the end of the micropuncture experiments (180 min) the W/D ratio was significantly increased, with respect to controls Table 1 for lungs used for biochemical determination of pulmonary PGs, extravascular lung fluid volume significantly increased already at 60 min both after collagenase (W/D ϭ 5.33 Ϯ 0.14, n ϭ 3, P Ͻ 0.05) and heparanase (W/D ϭ 5.48 Ϯ 0.3, n ϭ 3, P Ͻ 0.05) treatment. Although significantly elevated with respect to control, the lung W/D ratios observed in the treated lungs at both 60 and 180 min are compatible with a condition of mild to severe edema limited to the interstitial compartment. In fact, intratracheal foam, an index of alveolar edema, was never observed in the present experiments. Hence, the phenomena described in the present study pertain to the initial phase of pulmonary edema development.
Differences between collagenase and heparanase effects were observed also from the biochemical standpoint. The biochemical study and the micropuncture measurements were performed on different animal groups treated for the same time interval with the same enzymatic treatment. To describe the behavior of the lung as a whole, thereby avoiding the regional and individual variability of the lung tissue response to the enzymatic agent as witnessed by data presented in Fig. 1 , lung tissue specimens were pooled according to the collagenase or heparanase treatment and to the exposure time. Table 1 reports the total content of uronic acid in the dry lung tissue for the experimental conditions examined. The uronic acid derives from glucuronic and iduronic acids, which constitute the glycosaminoglycans linked to a core protein to shape families of PGs like chondroitin sulfate, dermatan sulfate, and heparin sulfate; hence, the uronic acid extraction is an index of glycosaminoglycan degradation. By considering that total tissue weight is given by the water content plus the dry tissue weight, we can calculate the uronic content expressed per dry tissue weight as the product of the uronic content per wet tissue weight by the W/D ratio. Data indicate that both enzymatic treatments resulted in an increased extractable fraction of uronic acid and thereby a decrease of the total uronic acid content of the tissue, suggesting the occurrence of a demolition and wash down of the constitutive matrix PG macromolecules. However, whereas the heparanase effect was essentially completed within the first 60 min of exposure, with collagenase the lesional effect developed more slowly, leading to a significant increase in extracted fraction and thus reduction of the uronic acid content in the lung only after 180 min. Hence, heparanase behaved as a much more aggressive agent.
To separate the different PG families, sequential gel chromatography was performed on the lung tissue extracts (Fig. 4,  A and B) . Gel exclusion liquid chromatography was performed twice on specimens of the same pooled tissues, and the areas under the elution curves were averaged. The elution patterns were highly reproducible with deviation between corresponding samples of Ͻ1%. The elution pattern of the same control samples is reported in Fig. 4, A and B , top. The chromatography profile showed three different peaks corresponding to three different PG families: large chondroitin-sulfate proteoglycans (CS-PG), mainly versican of Ͼ1 ϫ 10 6 Da (peak a); HS-PG, mainly perlecan, of 0.1-0.5 ϫ 10 6 Da (peak b); and small CS-PGs, mainly decorin of Ͻ0.1 ϫ 10 6 Da (peak c). After 60 min of enzymatic treatment, the versican peak was reduced, although not significantly, by both enzymatic treatments. However, the most important modification of the elution pattern consisted in the increase of material eluted in peak c, representing PG fragments likely deriving from cleavage of HS-PGs fraction belonging to peak b. After 180 min of both collagenase (Fig. 4A) and heparanase (Fig. 4B ) treatment, the versican component was further reduced with a relative increase of peak c.
The data presented in Fig. 4 , A and B, may be more clearly quantified in the histograms shown in Fig. 5A , in which the radioactive PG families separated in the gel filtration are expressed as percentage of the total amount of radioactivity eluted in the column. Data refer to the pooled values. The CS-PG (peak a), HS-PG (peak b), and decorin (peak c) fractions match those distinguished in the elution patterns of Fig. 4 ; material with molecular mass Ͻ20 ϫ 10 3 Da is also reported and accounts for smaller PG fragments.
As shown in Table 1 the total uronic extraction increased both with the enzymatic treatment and with the time of exposure. By multiplying the percentage distribution of extracted PGs presented in Fig. 5A by the uronic acid content reported in Table 1 for the experimental conditions encountered (control, collagenase 1 and 3 h, heparanase 1 and 3 h), we may evaluate the uronic acid content per unit dry tissue specifically deriving from each PG family eluted from the column (Fig. 5B) . This chemical analysis validated the radioactive data shown in Figs. 4 and 5A, confirming that the extracted material is more fragmented after the two enzymatic treatments. It is worth noting that, at 1 h, the only difference between the two treatments consists in the significant increase of the amount of material in peak c after heparanase treatment (P Ͻ 0.05), but not after collagenase (Figs. 4, A and B, and 5B). Considering that peak a did not significantly change at 60 min with respect to control, the increased peak c value may mainly derive from HS-PG demolition. At 3 h of exposure, collagenase and heparanase treatment determined a similar PG degradation. Indeed, the CS-PG fraction was significantly decreased, with respect to control, after both collagenase (P ϭ 0.004) and heparanase (P ϭ 0.008) treatments. Peak c was significantly increased after 3 h of collagenase (P Ͻ 0.001), similar to what observed for 3 h of heparanase (P ϭ 0.001). The eventual attainment of an extensive and comparable matrix degradation with both enzymatic treatments is in line with the similarity of the mechanical response of the lung parenchyma, i.e., with the 
DISCUSSION
P ip values result from several factors, including the balance between the rate of fluid filtration across the microvasculature and its subsequent reabsorption into the lymphatic system, the actual tissue hydration, and, last but not least, the stiffness of the interstitial fiber scaffold. The latter parameter may be estimated as the ratio between the change in tissue water content and the corresponding change in P ip (6) . In the normal lung, at any lung volume and at any lung height, P ip is always below atmospheric, as a result of a tensile stress exerted on a low compliant fiber matrix (7); in fact, P ip becomes even more negative, at the same tissue hydration, with further lung expansion. The present results show that exposure to proteolytic enzymes, such as collagenase and heparanase, affects lung fluid balance by determining an increased filtration rate as documented by the progressive slow increase of the extravascular lung water content (W/D ratio) and of the P ip values. Although the arterial and venous systemic pressures remained roughly constant throughout the experiment, the present data do not rule out the possibility that the increased filtration reflects a local raise of the pulmonary microvascular pressure induced by the exposure to the enzymes; at present no data are available to address this point, the discussion of which would deserve a separate study. However, on the basis of the effect of collagenase and heparanase (Figs. 4 and 5) , one might speculate that the increased filtration rate is at least partially related to an increased conductance of the pulmonary endothelium due to the direct cleaving activity of the enzymes on the endothelial layer and/or on the fiber matrix of the basal membrane.
Because at 1 h from the beginning of the enzymatic treatment the lung W/D ratio was essentially similar, a comparable increased in fluid filtration likely occurred in the two conditions. However, the novelty of the present data was to show that the mechanical response of the tissue, witnessed by the change in P ip , differed in that it was maintained after collagenase, but not after heparanase. This result, substantiated by both the P ip time course and the biochemical evidence, suggests that the integrity of the heparan-sulfate components of the pulmonary extracellular tissue matrix is required to maintain the three-dimensional architecture of the matrix itself and, in turn, to guarantee its mechanical response to increased fluid filtration. Hence, the HS-PG chains would play an important role not only in setting the sieving properties of the endothelial barrier, as constituents of the basement membrane, but also as stabilizing bonds between the other matrix macromolecules.
The results obtained in the present study following the treatment with collagenase extends and refines those obtained in a series of previous studies, showing that, in the intact rabbit lungs, the time course of P ip during development of interstitial lung edema appeared to be independent of the edema etiology. In fact, P ip invariably described a biphasic behavior, rising from a negative control value to a positive peak in the very initial phase to subsequently decline toward values approximately equal to atmospheric pressure, consistent with the complete release of local tissue stress.
This behavior has been repeatedly observed, although with some time course variability, during development of edema induced by 1) slow saline infusion (6), 2) unspecific protease treatment [pancreatic elastase (11) ], and 3) acute exposure to hypoxia [6 h at 12% O 2 in nitrogen (9)]. The common behavior of P ip has been interpreted in terms of the mechanical response of the solid tissue fibers framework to water accumulation: in the normal lung and until the solid interstitial scaffold remains integer, tissue stiffness provides a mechanical safeguard in that increased fluid entrance in the interstitial compartment determines a P ip increase that opposes further filtration into the tissue. The progressive rise toward positive P ip values observed during fluid accumulation is consistent with the development of a compressive tissue stress secondary to the protective role of the solid matrix. The latter, however, fails whenever the mechanical compliance of the tissue increases, a condition that has been observed to be associated with fragmentation either of large structural CS-PGs in case of hydraulic edema (6, 12) or of the HS-PGs in case of the nonspecific elastase-induced edema (11) . If it is true that the degradation of all PG families exposes the extracellular matrix to fluid accumulation, the present data reveal that even the mechanical response attributable to the CS-PGs component requires the integrity of the HS-PGs to be exerted.
In the normal tissue, resident blood monocytes and alveolar macrophages express various types of native collagenases belonging to a group of matrix metalloproteinases (MMP). The endogenous collagenases MMP-1 and MMP-9 specifically hydrolyze both intact and damaged collagen acting both intracellularly and extracellularly (1, 16) . Endogenous collagenases potentially degrade various types of native collagen, including type I and IV (16) . In addition, collagenases may cleave PGs by directly hydrolyzing their protein core; in fact, it has been shown that large chondroitin-sulfate-containing PGs (versican) isolated from the lung parenchyma of rabbits may be cleaved by purified gelatinase A (MMP-2) or B (MMP-9) (13). The increase in MMP expression and activity, depending either on direct addition of the enzyme in the circulating plasma, as in the collagenase or elastase treatments, or on indirect activation triggered by the mechanical stress imposed to the fiber scaffold, like during the development of hydraulic edema, seems to be the unifying factor motivating the similarity of the P ip time course during edema development. The fact that P ip attains a positive peak during the early phase of edema development suggests that, although MMPs activate a process of interstitial remodeling, interstitial stiffness is still close to normal and high enough to provide an effective mechanical response. From data in Figs. 4 and 5, it is clear that at 1 h after beginning of collagenase treatment, the high molecular versican fraction still accounts for the greatest proportion of the PG families. However, the integrity of versican (Fig. 5B) , likely linked to the collagen fibers, does not seem to guarantee per se the efficiency of the tissue safety factor. In fact, for a similar versican fraction and content, the mechanical response of the matrix fibers to fluid accumulation was still present after 60 min of collagenase, whereas it was lost after 60 min of heparanase. Hence heparanase, by specifically cleaving the HS-PG of the basement membranes, more significantly affected the mechanical response of the tissue to fluid influx. The architecture of the basement membrane acts not only as a barrier for fluid and solute efflux from the microvasculature, but also as a fiber network connecting the outer vascular wall to the surrounding interstitial space. Hence, fragmentation of the HS-PGs and, likely, of the other basement membrane macromolecules might functionally disconnect the rigid macromolecular interstitial scaffold from the microvascular wall, causing the loss of mechanical response of the tissue to fluid accumulation.
At 3 h of treatment, in the same manner and similarly to what was observed in the previous models of lesional (11) and hydraulic (12) edema, a significant degradation of all families of PGs is invariably associated to a nullified mechanical response of the matrix. In fact, high versican degradation observed after 3 h of collagenase treatment in the present study (Figs. 4 and 5 ) is associated with P ip values approaching zero (Figs. 1-3) , suggesting that mechanical tissue stress is completely released in this condition.
The heparanase used in the present study was chosen among the available commercialized molecules because of its specific ability to recognize the heparan sulfate chains as a primary substrate. HS-PGs consist of a core protein to which heparanate sulfate chains are covalently linked. They are ubiquitously distributed in the extracellular tissue matrix, particularly in the basal membranes as well as on the cell surface. In the lung, HS-PGs include perlecan in the epithelial and endothelial basement membranes and syndecan at the cell surface (2, 14, 17) . For their typical distribution and for the close interaction with collagen type IV, laminin, and fibronectin in the basement membranes (3, 5) , HS-PGs may be involved in providing the sieving properties of the endothelial wall. Cleavage of HS-PGs may therefore modify the permeability of the microvasculature endothelium to plasma components, including fluid, solutes of different sizes, and cells. Increased expression of endogenous mammalian heparanase has in fact been reported in sera and urine of metastatic tumor-bearing animals and patients (15) and correlates with the metastatic potential of various tumor cell types (4) . The results of the present study indicate that, unlike what is observed with collagenase, the protective role played by the solid component of the tissue matrix in counteracting fluid accumulation into the interstitial tissue is essentially lost as early as 60 min from the beginning of heparanase treatment. This suggests that the endoglycosidic cleavage operated by the heparanase on the HS-PG chains promotes a faster and/or more disruptive action on the extracellular fiber matrix compared with the cleavage of the protein component of the large PG molecules operated by collagenase. As evident from data of Fig. 5, A and B, although heparanase is specific for HS-PG, it also triggers the fragmentation of larger CS-containing PG, likely through activation of other endogenous metalloproteases, as suggested by finding that conditions as different as slow saline infusion (13) or hypoxia (9) induce the activation of systemic and /or tissue metalloproteases. Hence, one might conclude that the mechanical stiffness of the extracellular matrix is associated with the integrity of the glycosaminoglycan links of the PG macromolecules rather than with the core protein integrity.
Although the time course and the specific action of the two enzymes differed in their initial phase, the W/D ratio attained at the end of the experiments was similar (Table 1) . On the average the extravascular water content was increased by Ͼ30% compared with control, identifying a condition of interstitial lung edema, with no invasion of the alveolar air space. The cause of the rise of P ip values observed in the first 60 min of both enzymatic treatments is an augmented fluid influx into the interstitial space, likely due to an increased permeability of the endothelial barrier to plasma water and solutes. The fact that interstitial but not alveolar edema develops may be attributed to different factors: 1) the increased P ip values reduces the net hydraulic pressure gradient across the endothelial barrier, limiting fluid filtration. This effect would be more pronounced in collagenase experiments because of the attainment of a positive P ip peak (Figs. 1 and 3) ; 2) since hemodynamic parameters, such as blood pressure and plasma protein concentration, remain constant throughout the experiments, the pressure gradients supporting fluid filtration are not likely to increase over time, but if at all they tend to decrease; and 3) the efficiency of the injected enzymes in plasma and pulmonary tissue might be progressively reduced with time due to the action of resident antiproteolytic enzymes. Hence, the cleaving action of the enzymes might attenuate over time, arresting the fragmentation of the extracellular matrix.
The increase in total hexuronate extraction (Table 1) indicates that, although the relative changes in PG fraction are significant in the present experimental protocol, matrix degradation is still limited. This may not be the case if the enzymes are endogenously produced. For example, it has been recently observed that mechanical ventilation activates both resident and tissue metalloproteases (MMP-2 and MMP-9) leading to matrix degradation and edema development (10) . In this case the protracted lesional activity of the enzymes, if not inactivated, may actually determine a major lesion of the endothelial membrane and intra-alveolar extravasation of edema fluid.
In conclusion, the results of the present study indicate that the mechanical response of the pulmonary interstitial matrix in counteracting tissue fluid accumulation in situations of increased fluid filtration, a crucial factor in opposing interstitial edema development, not only is associated with the general macromolecular arrangement of the solid interstitial fiber matrix but specifically requires the integrity of the HS-PG components.
